Magnesium Sulfate, Solution for Injection, 250 Tender - 151922833

Procurement Summary

Country: Ukraine

Summary: Magnesium Sulfate, Solution for Injection, 250 Mg/Ml, 5 Ml Each; Papaverine, Solution for Injection, 20 Mg/Ml, 2 Ml Each; Sodium Chloride, Solution for Injection, 9 Mg/Ml, 5 Ml Each; Furosemide, Solution for Injection, 10Mg/M...

Deadline: 04 Nov 2026

Posting Date: 03 Nov 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 151922833

Document Ref. No.: UA-2026-11-01-000256-a

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: UAH 6945

CPV Classification

33600000 - Pharmaceutical products
33620000 - Medicinal products for the blood, blood-forming organs and the cardiovascular system
33610000 - Medicinal products for the alimentary tract and metabolism
33690000 - Various medicinal products
33670000 - Medicinal products for the respiratory system

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

Magnesium sulfate, solution for injection, 250 mg/ml, 5 ml each; Papaverine, solution for injection, 20 mg/ml, 2 ml each; Sodium chloride, solution for injection, 9 mg/ml, 5 ml each; Furosemide, solution for injection, 10 mg/ml, 2 ml each; Chloropyramine, solution for injection, 20 mg/ml, 1 ml each; Diphenhydramine, solution for injection, 10 mg/ml, 1 ml each; Metamizole sodium, solution for injection, 500 mg/ml, 2 ml; Prednisone, solution for injection, 30 mg/ml, 1 ml each; Theophylline solution for injection 20 mg/ml in 5 ml; Hydrogen peroxide, solution, 3%, 100 ml each; Ondansetron solution for injection 2 mg/ml in 4 ml; Chlorhexidine, solution for external use application of 0.05% per 100 ml; Diclofenac solution for injection 25 mg/ml; Dexamethasone, solution for injection 4mg/ml; Ammonia, solution for external use, 10%, 40 ml each; Acetylsalicylic acid tablets 75 mg; Clopidogrel, film-coated tablets, 75 mg each; Nitroglycerin, sublingual tablets, 0.5 mg each; Captopril/hydrochlorothiazide, tablets, 50/25 mg each
Purchase type: goods Classifier and its corresponding code: DK 021:2015: 33600000-6 — Pharmaceutical products Ondansetron solution for injections 2 mg/ml in 4 ml; Classification according to ATX: D08AC02, INN: Chlorhexidine, Release form: Solution for for external use, Dose of the active substance: 0.05%, Volume: 100 ml, Type of packaging: Vial; Classification according to INN: Acetylsalicylic acid, Classification according to ATX: B01AC06, Release form, Dose of active substance: 75 mg, Type of packaging: Blister, Vial, Strip Name Classifier and its corresponding codeQuantity/Measurement unitsPlace of deliveryDate of deliveryName
Classification according to ATX: D08AC02, INN: Chlorhexidine, Release form: Solution for external use, Dose of active substance: 0.05%, Volume: 100 ml, Type of packaging: Bottle; Classification according to INN: Acetylsalicylic acid, Classification according to ATX: B01AC06, Release form, Dose of active substance: 75 mg, Packaging type: Blister, Vial, Strip Name Classifier and its corresponding code Quantity/Units of measurement Place of delivery Date suppliesNazva

Documents

 Tender Notice